News

• NEW: Spring 2019 Newsletter
• NEW: Now Accepting Applications for the Mexico Pilot Program
• NEW: Important Changes to Postgraduate Training and Licensing Requirements
• NEW: Laws for 2019
  • AB 149 (Cooper) – Transition Period for Prescription Form Requirements Effective March 11, 2019
  • AB 1753 (Low, Chapter 479) – Prescription Form Requirements Effective January 1, 2019
  • Joint Statement from the California Department of Justice, California State Board of Pharmacy, and the Medical Board of California
  • AB 2760 (Wood, Chapter 324) – Naloxone Prescription Requirements Effective January 1, 2019
• Interested in becoming a volunteer physician? Check out the Board's Volunteer Physician Registry!
• CURES Mandatory Use Began October 2, 2018
  • CURES Mandatory Use FAQs

  The Controlled substance Utilization Review and Evaluation System (CURES) was certified for statewide use by the Department of Justice on April 2, 2018. Therefore, the mandate to consult CURES prior to prescribing, ordering, administering, or furnishing a Schedule II-IV controlled substance became effective October 2, 2018.

  CURES contains the following information: patient name, patient date of birth, patient address, prescriber name, prescriber DEA number, pharmacy name, pharmacy license number, date prescription was dispensed, prescription number, drug name, drug quantity and strength, and number of refills remaining.

  

  • View Online
  • View Fact Sheet

  
• Guidelines for the Recommendation of Cannabis for Medical Purposes
• 2017–2018 Annual Report
• Strategic Plan 2018–2021
• Sunset Review Report 2016